- Home
- CRGX vs PMF Comparison
CRGX vs PMF Comparison
Compare CRGX & PMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- PMF
- Stock Information
- Founded
- CRGX 2021
- PMF 2001
- Country
- CRGX United States
- PMF United States
- Employees
- CRGX N/A
- PMF N/A
- Industry
- CRGX
- PMF Finance/Investors Services
- Sector
- CRGX
- PMF Finance
- Exchange
- CRGX Nasdaq
- PMF Nasdaq
- Market Cap
- CRGX 213.5M
- PMF 207.9M
- IPO Year
- CRGX 2023
- PMF N/A
- Fundamental
- Price
- CRGX $4.02
- PMF $8.23
- Analyst Decision
- CRGX Hold
- PMF
- Analyst Count
- CRGX 7
- PMF 0
- Target Price
- CRGX $4.67
- PMF N/A
- AVG Volume (30 Days)
- CRGX 763.5K
- PMF 61.3K
- Earning Date
- CRGX 05-16-2025
- PMF 01-01-0001
- Dividend Yield
- CRGX N/A
- PMF 5.36%
- EPS Growth
- CRGX N/A
- PMF N/A
- EPS
- CRGX N/A
- PMF N/A
- Revenue
- CRGX N/A
- PMF N/A
- Revenue This Year
- CRGX $58.18
- PMF N/A
- Revenue Next Year
- CRGX N/A
- PMF N/A
- P/E Ratio
- CRGX N/A
- PMF N/A
- Revenue Growth
- CRGX N/A
- PMF N/A
- 52 Week Low
- CRGX $3.00
- PMF $7.69
- 52 Week High
- CRGX $25.45
- PMF $10.56
- Technical
- Relative Strength Index (RSI)
- CRGX 37.02
- PMF 48.66
- Support Level
- CRGX $3.97
- PMF $8.17
- Resistance Level
- CRGX $4.66
- PMF $8.34
- Average True Range (ATR)
- CRGX 0.20
- PMF 0.11
- MACD
- CRGX -0.05
- PMF 0.06
- Stochastic Oscillator
- CRGX 6.25
- PMF 79.63
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.